According to the Centers for Disease Control and Prevention (CDC), approximately 42% of Americans are obese, and 65% say ...

Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular weight loss drug Wegovy through new channels.

Body mass index (BMI) is the tool doctors use to calculate whether someone is underweight, at a healthy weight, overweight or obese. But because BMI calculations can't tell the difference between body ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, ...

Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...

Policy uncertainties are impacting biopharma dealmaking from continent to continent, with companies being asked to walk a ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.

The maker of Wegovy is making the GLP1 medication available to several telehealth companies.

Good morning. Amazon denies a reported tariff label plan after the White House blasted it as “hostile.” Novo Nordisk is ...